Lista de obras -

AFP measurement in monitoring treatment response of advanced hepatocellular carcinoma to sorafenib: case report and review of the literature.

artículo científico

Actin binding LIM protein 3 (abLIM3).

artículo científico publicado en 2006

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

artículo científico publicado en 2012

BlotBase: a northern blot database.

artículo científico publicado en 2008

CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.

artículo científico publicado en 2013

Clinicopathologic features and prognosis of young patients with hepatocellular carcinoma in a large German cohort.

artículo científico publicado en 2012

Colony-stimulating factor-1: a potential biomarker for lupus nephritis

artículo científico publicado en 2014

Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience

artículo científico publicado en 2013

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.

artículo científico publicado en 2015

Coupled variable selection for regression modeling of complex treatment patterns in a clinical cancer registry.

artículo científico publicado en 2014

Current bioinformatics tools in genomic biomedical research (Review).

artículo científico publicado en 2006

Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents.

artículo científico publicado en 2013

Diagnosis of and therapy for hepatocellular carcinoma

artículo científico publicado en 2013

Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients.

artículo científico publicado en 2013

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

scientific article published on 08 November 2019

Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients

artículo científico publicado en 2006

Genetics of hepatocellular carcinoma

artículo científico publicado en 2007

Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.

artículo científico publicado en 2013

Hepatocellular carcinoma in patients with autoimmune hepatitis.

artículo científico publicado en 2009

Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.

artículo científico publicado en 2006

How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?

artículo científico publicado en 2013

In silico characterization of LZTS3, a potential tumor suppressor.

artículo científico publicado en 2005

In silico characterization of an Iroquois family-related homeodomain protein.

artículo científico publicado en 2005

Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

artículo científico publicado en 2014

LASS6, an additional member of the longevity assurance gene family

artículo científico publicado en 2005

Library of molecular associations: curating the complex molecular basis of liver diseases.

artículo científico publicado en 2010

Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation

artículo científico publicado en 2012

Midterm follow-up after DC-BEAD™-TACE of hepatocellular carcinoma (HCC).

artículo científico publicado en 2012

Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients

artículo científico publicado en 2015

Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver.

artículo científico publicado en 2012

Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.

artículo científico publicado en 2014

Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.

artículo científico publicado en 2014

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

artículo científico publicado en 2016

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

artículo científico publicado en 2009

Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.

artículo científico publicado en 2014

Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.

artículo científico publicado en 2012

Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.

artículo científico publicado en 2013

Stagewise pseudo-value regression for time-varying effects on the cumulative incidence

artículo científico publicado en 2015

Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines

scientific article published on 01 November 1999

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment ⬇️

artículo científico publicado el 12 de noviembre de 2010

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

artículo científico publicado en 2006

Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients.

artículo científico publicado en 2014

TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis

scientific article published on 01 November 1996

The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib.

artículo científico publicado en 2012

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

artículo científico publicado en 2015

Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry

artículo científico publicado en 2014

[Etiology and complications of liver cirrhosis: data from a German centre].

artículo científico publicado en 2014

[Therapy of hepatocellular carcinoma]

scientific article published on 01 January 2014

Lista de obras de

AFP measurement in monitoring treatment response of advanced hepatocellular carcinoma to sorafenib: case report and review of the literature.

Actin binding LIM protein 3 (abLIM3).

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

BlotBase: a northern blot database.

CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines.

Clinicopathologic features and prognosis of young patients with hepatocellular carcinoma in a large German cohort.

Colony-stimulating factor-1: a potential biomarker for lupus nephritis

Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Coupled variable selection for regression modeling of complex treatment patterns in a clinical cancer registry.

Current bioinformatics tools in genomic biomedical research (Review).

Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents.

Diagnosis of and therapy for hepatocellular carcinoma

Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients.

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Genetic association of autoimmune hepatitis and human leucocyte antigen in German patients

Genetics of hepatocellular carcinoma

Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.

Hepatocellular carcinoma in patients with autoimmune hepatitis.

Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.

How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?

In silico characterization of LZTS3, a potential tumor suppressor.

In silico characterization of an Iroquois family-related homeodomain protein.

Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

LASS6, an additional member of the longevity assurance gene family

Library of molecular associations: curating the complex molecular basis of liver diseases.

Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation

Midterm follow-up after DC-BEAD™-TACE of hepatocellular carcinoma (HCC).

Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients

Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver.

Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial.

Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.

Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.

Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.

Stagewise pseudo-value regression for time-varying effects on the cumulative incidence

Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment ⬇️

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients.

TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis

The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib.

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry

[Etiology and complications of liver cirrhosis: data from a German centre].

[Therapy of hepatocellular carcinoma]